Our findings are similar to the results reported in a previous mouse study, which concluded that treatment with NVP-1704 led to the alleviation of depression/anxiety, changes in serum IL-6 levels, and an altered gut microbiome [17]. This evidence concerns the gene IL6 and depressive disorder.